GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 208 filers reported holding GENMAB A/S in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $107,154 | +10.3% | 3,335 | +11.5% | 0.01% | +25.0% |
Q2 2022 | $97,145 | -12.5% | 2,990 | -2.6% | 0.00% | 0.0% |
Q1 2022 | $111,073 | -10.4% | 3,070 | -2.0% | 0.00% | 0.0% |
Q4 2021 | $123,902 | +15.1% | 3,132 | +27.1% | 0.00% | 0.0% |
Q3 2021 | $107,677 | +50.0% | 2,464 | +40.2% | 0.00% | +33.3% |
Q2 2021 | $71,779 | +26.1% | 1,758 | +1.4% | 0.00% | +50.0% |
Q1 2021 | $56,927 | -16.0% | 1,734 | +4.0% | 0.00% | -33.3% |
Q4 2020 | $67,780 | +8.5% | 1,667 | -2.3% | 0.00% | -25.0% |
Q3 2020 | $62,493 | +85.1% | 1,707 | +71.4% | 0.00% | +100.0% |
Q2 2020 | $33,754 | +51.6% | 996 | -5.2% | 0.00% | 0.0% |
Q1 2020 | $22,271 | -5.2% | 1,051 | -0.1% | 0.00% | 0.0% |
Q4 2019 | $23,491 | +10.2% | 1,052 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $21,314 | – | 1,052 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |